Download PDF
Thromb Haemost 1976; 35(01): 151-166
DOI: 10.1055/s-0038-1647940
Original Article
Schattauer GmbH

In Vitro and in Vivo Functions of Thrombin-Treated Platelets[*]

Hans-Joachim Reimers
1   Department of Pathology, Mc Master University, Hamilton and Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
,
Raelene L. Kinlough-Rathbone
1   Department of Pathology, Mc Master University, Hamilton and Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
,
Jean-Pierre Cazenave
1   Department of Pathology, Mc Master University, Hamilton and Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
,
Andrew F. Senyi
1   Department of Pathology, Mc Master University, Hamilton and Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
,
Jack Hirsh
1   Department of Pathology, Mc Master University, Hamilton and Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
,
Marian A. Packham
1   Department of Pathology, Mc Master University, Hamilton and Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
,
J. Fraser Mustard
1   Department of Pathology, Mc Master University, Hamilton and Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Received 06 August 1975

accepted 06 August 1975

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

Summary

Thrombin-induced platelet aggregation has been generally believed to be irreversible. However, thrombin-induced aggregation of washed platelets is reversible if fibrin formation is prevented or the fibrin which binds the platelets together is removed from the platelet aggregates. After treatment with high concentrations of thrombin (0.5 units/ml) single platelets can be recovered that have lost practically all of their releasable serotonin and adenine nucleotides. These platelets are able to aggregate upon addition of low concentrations of ADP in the presence of fibrinogen. They aggregate in response to the ionophore A23, 187 in the absence of added fibrinogen, whereas sodium arachidonate-induced aggregation requires added fibrinogen. Thrombin-treated platelets change their shape in response to collagen in the absence of fibrinogen, and will aggregate upon the addition of collagen providing fibrinogen is present. This response to collagen can be blocked with aspirin but not with a mixture of creatine phosphate/creatine phosphokinase. Upon a second exposure to thrombin, thrombin-pretreated platelets do not change their shape and do not undergo aggregation. Thrombin-pretreated platelets will not retract a thrombin-induced fibrin clot unless ADP, sodium arachidonate, the ionophore A23, 187 or collagen are added together with thrombin.

The ability of thrombin-treated platelets to adhere to the exposed subendothelial surface of the rabbit aorta is reduced, compared with untreated control platelets. The thrombin-treated platelets shorten the bleeding time of thrombocytopenic rabbits. However, they are not as effective in shortening the bleeding time as normal control platelets. When injected into rabbits with a normal platelet count, the thrombin-treated platelets that circulate after infusion survive for the same length of time as untreated control platelets. These findings indicate that thrombin-induced platelet aggregation with extensive release of granule constituents is not irreversible and that thrombin treatment does not cause irreversible damage of all platelets that would lead to their immediate elimination from the circulation. Furthermore, these platelets can still be haemostatically effective. It is conceivable that platelets that have lost their amine storage granule contents during a release reaction in vivo, such as may occur in certain cases of intravascular coagulation and repeated episodes of thrombosis, may be found in the circulation of man.

* Presented at the Vth Congress of the International Society on Thrombosis and Haemostasis, Paris, July, 1975.


 

  • References

  • 1 Ardlie N. G, Packham M. A, Mustard J. F. 1970; Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. British Journal of Haematology 19: 7.
    CrossrefPubMedGoogle Scholar
  • 2 Ardlie N. G, Perry D. W, Packham M. A, Mustard J. F. 1971; Influence of apyrase on stability of suspensions of washed rabbit platelets. Proceedings of the Society for Experimental Biology and Medicine 136: 1021.
    PubMedGoogle Scholar
  • 3 Cazenave J.-P, Packham M. A, Guccione M. A, Mustard J. F. 1975; Inhibition of platelet adherence to damaged surface of rabbit aorta. Journal of Laboratory and Clinical Medicine 86: 551.
    PubMedGoogle Scholar
  • 4 Cowan D. H, Graham Jr. R. C, Bannach P. 1975; The platelet defect in leukemia. Platelet ultrastructure, adenine nucleotide metabolism, and the release reaction. Journal of Clinical Investigation 56: 188.
    CrossrefPubMedGoogle Scholar
  • 5 Czernobilsky H, Alexander B. 1961. Some qualitative and quantitative aspects of platelet function in normal, thrombocytopenic, and thrombocytopathic states. In: Johnson S. A, Monto R. W, Rebuck J. W, Horn Jr. R. C. (eds.) Blood Platelets. Little; Brown & Co., Boston, Mass.: 565.
    Google Scholar
  • 6 Davis J. W. 1973; Defective platelet disaggregation associated with occlusive arterial disease. Angiology 24: 391.
    CrossrefPubMedGoogle Scholar
  • 7 DeGaetano G, Bottechia D, Vermylen F. 1973; Retraction of reptilase clots in the presence of agents inducing or inhibiting the platelet adhesion-aggregation reaction. Thrombosis Research 2: 71.
    CrossrefPubMedGoogle Scholar
  • 8 DeClerck F, Borgers M, DeGaetano G, Vermylen F. 1975; Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of reptilase-human platelet rich plasma clots. British Journal of Haematology 29: 341.
    CrossrefPubMedGoogle Scholar
  • 9 Dreyfuss F, Zahavi J. 1973; Adenosine diphosphate-induced platelet aggregation in myocardial infarction and ischemic heart disease. Atherosclerosis 17: 107.
    CrossrefPubMedGoogle Scholar
  • 10 Egberg N, Johnsson H. 1972; Platelet aggregation induced by ADP and thrombin in reptilase defibrinated dogs. Thrombosis Research 1: 95.
    CrossrefPubMedGoogle Scholar
  • 11 Greenberg J, Packham M. A, Cazenave J.-P, Reimers H. J, Mustard J. F. 1975; Effects on platelet function of removal of platelet sialic acid by neuraminidase. Laboratory Investigation 32: 476.
    PubMedGoogle Scholar
  • 12 Grette K. 1962; Studies on the mechanism of thrombin-catalyzed hemostatic reactions in blood platelets. Acta Physiologica Scandinavica 56 Suppl. 195
    PubMedGoogle Scholar
  • 13 Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. 1974; Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proceedings of the National Academy of Sciences 71: 345.
    CrossrefPubMedGoogle Scholar
  • 14 Harbury C. B, Schrier S. L. 1974; The effect of a partial release reaction on subsequent platelet function. Journal of Laboratory and Clinical Medicine 83: 877.
    PubMedGoogle Scholar
  • 15 Haslam R. J. 1967. Mechanisms of blood platelet aggregation. In: Johnson S. A, Seegers W. H. (eds.) Physiology of Haemostasis and Thrombosis. Charles C. Thomas; Springfield, 111.: 88.
    Google Scholar
  • 16 Kinlough-Rathbone R. L, Packham M. A, Mustard J. F. 1970; The effect of prostaglandin E1 on platelet functions in vivo and in vitro. British Journal of Haematology 19: 559.
    CrossrefPubMedGoogle Scholar
  • 17 Kinlough-Rathbone R. L, Chahil A, Packham M. A, Reimers H. J, Mustard J. F. 1975; Effect of A23,187 on thrombin-degranulated washed rabbit platelets. Thrombosis Research 7: 435.
    CrossrefPubMedGoogle Scholar
  • 18 Lüscher E. F. 1956; Viscous metamorphosis of blood platelets and clot retraction. Vox Sang 1: 133.
    CrossrefPubMedGoogle Scholar
  • 19 Mills D. C. B, Roberts G. C. K. 1967; Membrane active drugs and the aggregation of human blood platelets. Nature 213: 35.
    CrossrefPubMedGoogle Scholar
  • 20 Molnar J, Lorand L. 1961; Studies on apyrases. Archives of Biochemistry and Biophysics 93: 353.
    CrossrefPubMedGoogle Scholar
  • 21 Morse E. E, Jackson D. P, Conley C. L. 1965; Role of platelet fibrinogen in the reactions of platelets to thrombin. Journal of Clinical Investigation 44: 809.
    CrossrefPubMedGoogle Scholar
  • 22 Mürer E. M. 1972. Biochemical aspects of clot retraction and the platelet release reaction. Thesis Universitetforloget; Oslo:
    Google Scholar
  • 23 Mustard J. F, Hegardt B, Rowsell H. C, MacMillan R. L. 1964; Effect of adenosine nucleotides on platelet aggregation and clotting time. Journal of Laboratory and Clinical Medicine 64: 548.
    PubMedGoogle Scholar
  • 24 Mustard J. F, Rowsell H. C, Murphy E. A. 1966; Platelet economy (platelet survival and turnover). British Journal of Haematology 12: 1.
    CrossrefPubMedGoogle Scholar
  • 25 Mustard J. F, Packham M. A. 1970; Factors influencing platelet function: adhesion, release, and aggregation. Pharmacological Reviews 22: 97.
    PubMedGoogle Scholar
  • 26 Mustard J. F, Packham M. A. 1971. The reaction of blood to injury. In: Movat H. Z. (ed.) Inflammation, Immunity and Hypersensitivity. Harper & Row; New York: 527.
    Google Scholar
  • 27 Mustard J. F, Perry D. W, Kinlough-Rathbone R. L, Packham M. A. 1975; a Factors responsible for ADP-induced release reaction of human platelets. American Journal of Physiology 228: 1757.
    PubMedGoogle Scholar
  • 28 Mustard J. F, Kinlough-Rathbone R. L, Reimers H. J, Perry D. W, Packham M. A. 1975 b Inhibition of collagen- and thrombin-induced shape change of rabbit platelets. Vth Congress of the International Society on Thrombosis and Haemostasis, Paris, Abstract, p. 8.
    PubMedGoogle Scholar
  • 29 O’Brien J. R, Etherington M, Jamieson S. 1971; Refractory state of platelet aggregation with major operation. Lancet 2: 741.
    PubMedGoogle Scholar
  • 30 O’Brien J. R, Etherington M, Jamieson S. 1972; Platelet function in venous thrombosis and low dosage heparin. Lancet 1: 1302.
    PubMedGoogle Scholar
  • 31 Packham M. A, Warrior E. S, Glynn M. F, Senyi A. S, Mustard J. F. 1967; Alteration of the response of platelets to surface stimuli by pyrazole compounds. Journal of Experimental Medicine 126: 171.
    CrossrefPubMedGoogle Scholar
  • 32 Packham M. A, Guccione M. A, Perry D. W, Mustard J. F. 1974; Interactions of nucleoside di- and triphosphates with rabbit platelets. American Journal of Physiology 227: 1143.
    PubMedGoogle Scholar
  • 33 Pareti F, Capltanio A, Chantarangkul V, Mannucci P. M. 1975. Acquired storage pool deficiency in platelets during DIC. Vth Congress of the International Society on Thrombosis and Haemostasis . Paris: 1975. Abstract p. 154.
    Google Scholar
  • 34 Parmeggiani A. 1961; Elektronenoptische Beobachtungen an menschlichen Blutplättchen während der viskösen Metamorphose. Thrombosis et Diathesis Haemorrhagica 6: 517.
    PubMedGoogle Scholar
  • 35 Phillips P. R, Agin P. P. 1973; Thrombin-induced alterations in the surface structure of the human platelet plasma membrane. Series Haematologica VI: 292.
    PubMedGoogle Scholar
  • 36 Pressman B. C. 1973; Properties of ionophores with broad range cation selectivity. Federation Proceedings 32: 1698.
    PubMedGoogle Scholar
  • 37 Reimers H. J, Packham M. A, Kinlough-Rathbone R. L, Mustard J. F. 1973; a Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism, and survival. British Journal of Haematology 25: 675.
    CrossrefPubMedGoogle Scholar
  • 38 Reimers H. J, Buchanan M. R, Mustard J. F. 1973; b Survival of washed rabbit platelets in vivo. Proceedings of the Society for Experimental Biology and Medicine 142: 1222.
    PubMedGoogle Scholar
  • 39 Reimers H. J, Allen D. J, Feuerstein I. A, Mustard J. F. 1975; Transport and storage of serotonin by thrombin-treated platelets. Journal of Cell Biology 65: 359.
    CrossrefPubMedGoogle Scholar
  • 40 Schmtd H. J, Jackson D. P, Conley C. L. 1962; Mechanism of action of thrombin on platelets. Journal of Clinical Investigation 11: 543.
    PubMedGoogle Scholar
  • 41 Thomas D. P. 1967; Effects of catecholamines on platelet aggregation caused by thrombin. Nature 215: 298.
    CrossrefPubMedGoogle Scholar
  • 42 Zahavi J, Marder V. J. 1974; Acquired “storage pool disease” of platelets associated with circulating antiplatelet antibodies. American Journal of Medicine 56: 883.
    CrossrefPubMedGoogle Scholar
  • 43 Zucker M. B, Peterson J. 1970; Effect of acetylsalicylie acid, other nonsteroidal antiinflammatory agents, and dipyridamole on human blood platelets. Journal of Laboratory and Clinical Medicine 76: 66.
    PubMedGoogle Scholar
  • 44 Zuzel M. 1971. ADP induced aggregation of blood platelets released from clots by fibrinolysis in vitro. 2nd Congress of the International Society on Thrombosis and Haemostasis . Oslo, Norway: Abstract p. 278.
    Google Scholar